Etidronate and trisphosphonates are new potential candidates for neuroprotective drugs for Alzheimer

来源 :The 6th FAONS Congress and 11th Biennial Conference of CNS(第 | 被引量 : 0次 | 上传用户:2034912
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Objective Bisphosphonates(BP)is a category of drugs that are used to treat various bone diseases,such as osteoporosis,Pagets disease,bone malignancy and other skeletal complications involving excessively bone losses.
其他文献
Spinocerebellar ataxia type 3/Machado-Joseph disease(SCA3/MJD)is the most common subtypes of spinocerebellar ataxias in China,which belong to the polyglutamine diseases.
Oxidative stress and neuroinflammation are early events associated with dopaminergic neuronal degeneration in Parkinsons disease(PD).
Objective Cytokines IL-6 and TNF-α were associated with inflammatory pain.
Objective:To optimize the conditions of transfecting eukaryotic expression vector pEGFP-N1 into neural stem cells(NSCs)from rats by CUY21EDITII electroporator,in order to improve the transfection effi
objective Alzheimers disease(AD)is the most common form of dementia in the elderly,and its core symptom is progressive cognitive dysfunction.
Objective: Alzheimers disease(AD)is a neurodegenerative disease.The two obvious neuropatholopgical changes in AD are senile plaques(SP)and neurofibrillary tangles(NFT).
Early,reliable and non-invasive diagnosis of Alzheimer disease(AD)is a great challenge,which makes the prognosis and therapeutic interventions quite difficult.
Parkinsons disease(PD)is a progressive neurodegenerative movement disorder that is caused predominantly by the degeneration of the nigrostriatal dopaminergic pathway.
会议
Objective Alzheimer disease is characterized by progressive memory loss and damaging of cognitive functions.